The Saudi General Authority for Competition (GAC) approved, on Oct. 6, the economic concentration arising from Dallah Healthcare Co.’s planned acquisition of a 58.64% stake in Care Shield Holding Co., a subsidiary of Kingdom Investment and Development Co.
According to the data compiled by Argaam, Dallah Healthcare signed, on May 15, 2020 a final agreement to buy a 58.64% stake in Care Shield, through share swap and cash consideration.
The deal completion is still subject to a number of conditions, including, the approval of the relevant governmental authorities.
Dallah Healthcare will disclose the relevant material updates in due course.
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}